Position in HLN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$159,076
-$190,273 QoQ
Shares Held
17,050
-51.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#318
of 640 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $1,705,003 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,932 | $641,853 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,640 | $326,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
13,597 | $217,959 | |
| 4 | VTRS |
Viatris Inc
|
12,852 | $204,089 | |
| 5 | HLN |
Haleon plc
This page
|
17,050 | $159,076 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
31,526 | $155,423 |
All Filings in HLN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $159,076 | 17,050 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $349,349 | 34,900 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $441,857 | 43,705 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $444,400 | 49,543 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $878,784 | 84,743 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $679,860 | 66,070 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $449,324 | 47,099 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $215,355 | 20,355 | Shares | Sole | 2024-10-15 | |
| No filing history on record for this holder in this stock. | ||||||